Corticosteroids and neuromuscular blockers in development of critical illness neuromuscular abnormalities: A historical review

Journal of Critical Care

Volumn 37, Issue , 2017, Pages 149-155

  Wilcox, Susan R ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Corticosteroids; Myopathy; Neuromuscular blockade; Polyneuropathy; Weakness

Indexed keywords

CISATRACURIUM; CORTICOSTEROID; NEUROMUSCULAR BLOCKING AGENT;

ARTIFICIAL VENTILATION; CASE STUDY; CLINICAL PRACTICE; CRITICAL ILLNESS; DRUG MEGADOSE; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; INTENSIVE CARE UNIT; MORBIDITY; MUSCLE WEAKNESS; NEUROMUSCULAR DISEASE; OBSERVATIONAL STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SEPSIS; TREATMENT DURATION; CHEMICALLY INDUCED; HISTORY; INTENSIVE CARE; UNITED STATES;

ADRENAL CORTEX HORMONES; CRITICAL CARE; CRITICAL ILLNESS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INTENSIVE CARE UNITS; MUSCLE WEAKNESS; NEUROMUSCULAR BLOCKING AGENTS; RESPIRATION, ARTIFICIAL; UNITED STATES;

EID: 85006102678     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2016.09.018     Document Type: Review

References (121)

1. [1] Petrof, B.J., Hussain, S.N., Ventilator-induced diaphragmatic dysfunction: what have we learned?. Curr Opin Crit Care, 2015.
2. [2] De Jonghe, B., Sharshar, T., Hopkinson, N., Outin, H., Paresis following mechanical ventilation. Curr Opin Crit Care 10 (2004), 47–52.
3. [3] MacFarlane, I.A., Rosenthal, F.D., Severe myopathy after status asthmaticus. Lancet, 2, 1977, 615.
4. [4] Sher, J.H., Shafiq, S.A., Schutta, H.S., Acute myopathy with selective lysis of myosin filaments. Neurology 29 (1979), 100–106.
5. [5] Van Marle, W., Woods, K.L., Acute hydrocortisone myopathy. Br Med J 281 (1980), 271–272.
6. [6] Op de Coul, A.A., Lambregts, P.C., Koeman, J., van Puyenbroek, M.J., Ter Laak, H.J., Gabreels-Festen, A.A., Neuromuscular complications in patients given Pavulon (pancuronium bromide) during artificial ventilation. Clin Neurol Neurosurg 87 (1985), 17–22.
7. [7] Kupfer, Y., Okrent, D.G., Twersky, R.A., Tessler, S., Disuse atrophy in a ventilated patient with status asthmaticus receiving neuromuscular blockade. Crit Care Med 15 (1987), 795–796.
8. [8] Ramsay, D.A., Zochodne, D.W., Robertson, D.M., Nag, S., Ludwin, S.K., A syndrome of acute severe muscle necrosis in intensive care unit patients. J Neuropathol Exp Neurol 52 (1993), 387–398.
9. [9] Zochodne, D.W., Ramsay, D.A., Saly, V., Shelley, S., Moffatt, S., Acute necrotizing myopathy of intensive care: electrophysiological studies. Muscle Nerve 17 (1994), 285–292.
10. [10] Hydrocortisone and pancuronium bromide: acute myopathy during status asthmaticus. Crit Care Med, 16, 1988, 731–733.
11. [11] Margolis, B.D., Khachikian, D., Friedman, Y., Garrard, C., Prolonged reversible quadriparesis in mechanically ventilated patients who received long-term infusions of vecuronium. Chest 100 (1991), 877–878.
12. [12] Giostra, E., Magistris, M.R., Pizzolato, G., Cox, J., Chevrolet, J.C., Neuromuscular disorder in intensive care unit patients treated with pancuronium bromide. Occurrence in a cluster group of seven patients and two sporadic cases, with electrophysiologic and histologic examination. Chest 106 (1994), 210–220.
13. [13] Deem, S., Intensive-care-unit–acquired muscle weakness. Respir Care, 51, 2006 [1042,52; discussion 1052–3].
14. [14] Papazian, L., Forel, J.M., Gacouin, A., Penot-Ragon, C., Perrin, G., Loundou, A., et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 363 (2010), 1107–1116.
15. [15] Szakmany, T., Woodhouse, T., Use of cisatracurium in critical care: a review of the literature. Minerva Anestesiol 81 (2015), 450–460.
16. [16] Alhazzani, W., Alshahrani, M., Jaeschke, R., Forel, J.M., Papazian, L., Sevransky, J., et al. Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials. Crit Care, 17, 2013, R43.
17. [17] Hraiech, S., Yoshida, T., Papazian, L., Balancing neuromuscular blockade versus preserved muscle activity. Curr Opin Crit Care 21 (2015), 26–33.
18. [18] Osias, J., Manno, E., Neuromuscular complications of critical illness. Crit Care Clin 30 (2014), 785–794.
19. [19] Apostolakis, E., Papakonstantinou, N.A., Baikoussis, N.G., Papadopoulos, G., Intensive care unit-related generalized neuromuscular weakness due to critical illness polyneuropathy/myopathy in critically ill patients. J Anesth 29 (2015), 112–121.
20. [20] Lipshutz, A.K., Gropper, M.A., Acquired neuromuscular weakness and early mobilization in the intensive care unit. Anesthesiology 118 (2013), 202–215.
21. [21] Gorson, K.C., Approach to neuromuscular disorders in the intensive care unit. Neurocrit Care 3 (2005), 195–212.
22. [22] Jolley, S.E., Bunnell, A., Hough, C.L., Intensive care unit acquired weakness. Chest pii:S0012-3692:16 (2016), 47575–47576, 10.1016/j.chest.2016.03.045 [Epub ahead of print].
23. [23] De Jonghe, B., Cook, D., Sharshar, T., Lefaucheur, J.P., Carlet, J., Outin, H., Acquired neuromuscular disorders in critically ill patients: a systematic review. Groupe de Reflexion et d'Etude sur les Neuromyopathies En Reanimation. Intensive Care Med 24 (1998), 1242–1250.
24. [24] Baird, W.L., Reid, A.M., The neuromuscular blocking properties of a new steroid compound, pancuronium bromide. A pilot study in man. Br J Anaesth 39 (1967), 775–780.
25. [25] Appiah-Ankam, J., Hunter, J.M., Pharmacology of neuromuscular blocking drugs. Br J Anaesth Contin Educ Anaesth Crit Care Pain 4 (2004), 2–7.
26. [26] Docherty, J.R., McGrath, J.C., A comparison of the effects of pancuronium bromide and its monoquaternary analogue, ORG NC 45, on autonomic and somatic neurotransmission in the rat. Br J Pharmacol 71 (1980), 225–233.
27. [27] Payne, J.P., Hughes, R., Evaluation of atracurium in anaesthetized man. Br J Anaesth 53 (1981), 45–54.
28. [28] Wierda, J.M., de Wit, A.P., Kuizenga, K., Agoston, S., Clinical observations on the neuromuscular blocking action of Org 9426, a new steroidal non-depolarizing agent. Br J Anaesth 64 (1990), 521–523.
29. [29] Prielipp, R.C., Coursin, D.B., Scuderi, P.E., Bowton, D.L., Ford, S.R., Cardenas, V.J. Jr., et al. Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51 W89 in intensive care unit patients. Anesth Analg 81 (1995), 3–12.
30. [30] Bolton, C.F., Neuromuscular complications of sepsis. Intensive Care Med 19:Suppl. 2 (1993), S58–S63.
31. [31] Lacomis, D., Smith, T.W., Chad, D.A., Acute myopathy and neuropathy in status asthmaticus: case report and literature review. Muscle Nerve 16 (1993), 84–90.
32. [32] Hanson, P., Dive, A., Brucher, J.M., Bisteau, M., Dangoisse, M., Deltombe, T., Acute corticosteroid myopathy in intensive care patients. Muscle Nerve 20 (1997), 1371–1380.
33. [33] Hirano, M., Ott, B.R., Raps, E.C., Minetti, C., Lennihan, L., Libbey, N.P., et al. Acute quadriplegic myopathy: a complication of treatment with steroids, nondepolarizing blocking agents, or both. Neurology 42 (1992), 2082–2087.
34. [34] Barohn, R.J., Jackson, C.E., Rogers, S.J., Ridings, L.W., McVey, A.L., Prolonged paralysis due to nondepolarizing neuromuscular blocking agents and corticosteroids. Muscle Nerve 17 (1994), 647–654.
35. [35] Lacomis, D., Giuliani, M.J., Van Cott, A., Kramer, D.J., Acute myopathy of intensive care: clinical, electromyographic, and pathological aspects. Ann Neurol 40 (1996), 645–654.
36. [36] Road, J., Mackie, G., Jiang, T.X., Stewart, H., Eisen, A., Reversible paralysis with status asthmaticus, steroids, and pancuronium: clinical electrophysiological correlates. Muscle Nerve 20 (1997), 1587–1590.
37. [37] Coakley, J.H., Nagendran, K., Ormerod, I.E., Ferguson, C.N., Hinds, C.J., Prolonged neurogenic weakness in patients requiring mechanical ventilation for acute airflow limitation. Chest 101 (1992), 1413–1416.
38. [38] Picado, C., Montserrat, J., Agusti-Vidal, A., Muscle atrophy in severe exacerbation of asthma requiring mechanical ventilation. Respiration 53 (1988), 201–203.
39. [39] Larsson, L., Li, X., Edstrom, L., Eriksson, L.I., Zackrisson, H., Argentini, C., et al. Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: mechanisms at the cellular and molecular levels. Crit Care Med 28 (2000), 34–45.
40. [40] Griffin, D., Fairman, N., Coursin, D., Rawsthorne, L., Grossman, J.E., Acute myopathy during treatment of status asthmaticus with corticosteroids and steroidal muscle relaxants. Chest 102 (1992), 510–514.
41. [41] Knox, A.J., Mascie-Taylor, B.H., Muers, M.F., Acute hydrocortisone myopathy in acute severe asthma. Thorax 41 (1986), 411–412.
42. [42] Clore, J.N., Thurby-Hay, L., Glucocorticoid-induced hyperglycemia. Endocr Pract 15 (2009), 469–474.
43. [43] Rosenberg, S.G., Atracurium and prolonged muscle weakness. Anesth Analg, 79, 1994, 1211.
44. [44] Branney, S.W., Haenel, J.B., Moore, F.A., Tarbox, B.B., Schreiber, R.H., Moore, E.E., Prolonged paralysis with atracurium infusion: a case report. Crit Care Med 22 (1994), 1699–1701.
45. [45] Hoey, L.L., Joslin, S.M., Nahum, A., Vance-Bryan, K., Prolonged neuromuscular blockade in two critically ill patients treated with atracurium. Pharmacotherapy 15 (1995), 254–259.
46. [46] Meyer, K.C., Prielipp, R.C., Grossman, J.E., Coursin, D.B., Prolonged weakness after infusion of atracurium in two intensive care unit patients. Anesth Analg 78 (1994), 772–774.
47. [47] Davis, N.A., Rodgers, J.E., Gonzalez, E.R., Fowler, A.A. III, Prolonged weakness after cisatracurium infusion: a case report. Crit Care Med 26 (1998), 1290–1292.
48. [48] Fodale, V., Pratico, C., Girlanda, P., Baradello, A., Lucanto, T., Rodolico, C., et al. Acute motor axonal polyneuropathy after a cisatracurium infusion and concomitant corticosteroid therapy. Br J Anaesth 92 (2004), 289–293.
49. [49] Douglass, J.A., Tuxen, D.V., Horne, M., Scheinkestel, C.D., Weinmann, M., Czarny, D., et al. Myopathy in severe asthma. Am Rev Respir Dis 146 (1992), 517–519.
50. [50] Garnacho-Montero, J., Madrazo-Osuna, J., Garcia-Garmendia, J.L., Ortiz-Leyba, C., Jimenez-Jimenez, F.J., Barrero-Almodovar, A., et al. Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med 27 (2001), 1288–1296.
51. [51] Campellone, J.V., Lacomis, D., Kramer, D.J., Van Cott, A.C., Giuliani, M.J., Acute myopathy after liver transplantation. Neurology 50 (1998), 46–53.
52. [52] Kupfer, Y., Namba, T., Kaldawi, E., Tessler, S., Prolonged weakness after long-term infusion of vecuronium bromide. Ann Intern Med 117 (1992), 484–486.
53. [53] Leatherman, J.W., Fluegel, W.L., David, W.S., Davies, S.F., Iber, C., Muscle weakness in mechanically ventilated patients with severe asthma. Am J Respir Crit Care Med 153 (1996), 1686–1690.
54. [54] Adnet, F., Dhissi, G., Borron, S.W., Galinski, M., Rayeh, F., Cupa, M., et al. Complication profiles of adult asthmatics requiring paralysis during mechanical ventilation. Intensive Care Med 27 (2001), 1729–1736.
55. [55] Behbehani, N.A., Al-Mane, F., D'yachkova, Y., Pare, P., FitzGerald, J.M., Myopathy following mechanical ventilation for acute severe asthma: the role of muscle relaxants and corticosteroids. Chest 115 (1999), 1627–1631.
56. [56] Arroliga, A., Frutos-Vivar, F., Hall, J., Esteban, A., Apezteguia, C., Soto, L., et al. Use of sedatives and neuromuscular blockers in a cohort of patients receiving mechanical ventilation. Chest 128 (2005), 496–506.
57. [57] Leijten, F.S., Harinck-de Weerd, J.E., Poortvliet, D.C., de Weerd, A.W., The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation. JAMA 274 (1995), 1221–1225.
58. [58] Leijten, F.S., De Weerd, A.W., Poortvliet, D.C., De Ridder, V.A., Ulrich, C., Harink-De Weerd, J.E., Critical illness polyneuropathy in multiple organ dysfunction syndrome and weaning from the ventilator. Intensive Care Med 22 (1996), 856–861.
59. [59] de Letter, M.A., Schmitz, P.I., Visser, L.H., Verheul, F.A., Schellens, R.L., Op de Coul, D.A., et al. Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med 29 (2001), 2281–2286.
60. [60] Amaya-Villar, R., Garnacho-Montero, J., Garcia-Garmendia, J.L., Madrazo-Osuna, J., Garnacho-Montero, M.C., Luque, R., et al. Steroid-induced myopathy in patients intubated due to exacerbation of chronic obstructive pulmonary disease. Intensive Care Med 31 (2005), 157–161.
61. [61] Witt, N.J., Zochodne, D.W., Bolton, C.F., Grand'Maison, F., Wells, G., Young, G.B., et al. Peripheral nerve function in sepsis and multiple organ failure. Chest 99 (1991), 176–184.
62. [62] De Jonghe, B., Sharshar, T., Lefaucheur, J.P., Authier, F.J., Durand-Zaleski, I., Boussarsar, M., et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 288 (2002), 2859–2867.
63. [63] Coakley, J.H., Nagendran, K., Honavar, M., Hinds, C.J., Preliminary observations on the neuromuscular abnormalities in patients with organ failure and sepsis. Intensive Care Med 19 (1993), 323–328.
64. [64] Coakley, J.H., Nagendran, K., Yarwood, G.D., Honavar, M., Hinds, C.J., Patterns of neurophysiological abnormality in prolonged critical illness. Intensive Care Med 24 (1998), 801–807.
65. [65] Hund, E.F., Fogel, W., Krieger, D., DeGeorgia, M., Hacke, W., Critical illness polyneuropathy: clinical findings and outcomes of a frequent cause of neuromuscular weaning failure. Crit Care Med 24 (1996), 1328–1333.
66. [66] Sassoon, C.S., Zhu, E., Pham, H.T., Nelson, R.S., Fang, L., Baker, M.J., et al. Acute effects of high-dose methylprednisolone on diaphragm muscle function. Muscle Nerve 38 (2008), 1161–1172.
67. [67] Maes, K., Testelmans, D., Cadot, P., Deruisseau, K., Powers, S.K., Decramer, M., et al. Effects of acute administration of corticosteroids during mechanical ventilation on rat diaphragm. Am J Respir Crit Care Med 178 (2008), 1219–1226.
68. [68] Maes, K., Agten, A., Smuder, A., Powers, S.K., Decramer, M., Gayan-Ramirez, G., Corticosteroid effects on ventilator-induced diaphragm dysfunction in anesthetized rats depend on the dose administered. Respir Res, 11, 2010 [178,9921–11-178].
69. [69] Testelmans, D., Maes, K., Wouters, P., Gosselin, N., Deruisseau, K., Powers, S., et al. Rocuronium exacerbates mechanical ventilation–induced diaphragm dysfunction in rats. Crit Care Med 34 (2006), 3018–3023.
70. [70] Maes, K., Testelmans, D., Thomas, D., Decramer, M., Gayan-Ramirez, G., High dose methylprednisolone counteracts the negative effects of rocuronium on diaphragm function. Intensive Care Med 37 (2011), 1865–1872.
71. [71] Testelmans, D., Maes, K., Wouters, P., Powers, S.K., Decramer, M., Gayan-Ramirez, G., Infusions of rocuronium and cisatracurium exert different effects on rat diaphragm function. Intensive Care Med 33 (2007), 872–879.
72. [72] Bercker, S., Weber-Carstens, S., Deja, M., Grimm, C., Wolf, S., Behse, F., et al. Critical illness polyneuropathy and myopathy in patients with acute respiratory distress syndrome. Crit Care Med 33 (2005), 711–715.
73. [73] Annane, D., Sebille, V., Charpentier, C., Bollaert, P.E., Francois, B., Korach, J.M., et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288 (2002), 862–871.
74. [74] Confalonieri, M., Urbino, R., Potena, A., Piattella, M., Parigi, P., Puccio, G., et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med 171 (2005), 242–248.
75. [75] Steinberg, K.P., Hudson, L.D., Goodman, R.B., Hough, C.L., Lanken, P.N., Hyzy, R., et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 354 (2006), 1671–1684.
76. [76] Meduri, G.U., Golden, E., Freire, A.X., Taylor, E., Zaman, M., Carson, S.J., et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest 131 (2007), 954–963.
77. [77] Lee, C.H., Peng, M.J., Wu, C.L., Dexamethasone to prevent postextubation airway obstruction in adults: a prospective, randomized, double-blind, placebo-controlled study. Crit Care, 11, 2007, R72.
78. [78] Sprung, C.L., Annane, D., Keh, D., Moreno, R., Singer, M., Freivogel, K., et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 358 (2008), 111–124.
79. [79] COIITSS Study Investigators, Annane, D., Cariou, A., Maxime, V., Azoulay, E., D'honneur, G., et al. Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA 303 (2010), 341–348.
80. [80] Mentzelopoulos, S.D., Malachias, S., Chamos, C., Konstantopoulos, D., Ntaidou, T., Papastylianou, A., et al. Vasopressin, steroids, and epinephrine and neurologically favorable survival after in-hospital cardiac arrest: a randomized clinical trial. JAMA 310 (2013), 270–279.
81. [81] Gainnier, M., Roch, A., Forel, J.M., Thirion, X., Arnal, J.M., Donati, S., et al. Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome. Crit Care Med 32 (2004), 113–119.
82. [82] Forel, J.M., Roch, A., Marin, V., Michelet, P., Demory, D., Blache, J.L., et al. Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome. Crit Care Med 34 (2006), 2749–2757.
83. [83] Tang, B.M., Craig, J.C., Eslick, G.D., Seppelt, I., McLean, A.S., Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care Med 37 (2009), 1594–1603.
84. [84] Stevens, R.D., Dowdy, D.W., Michaels, R.K., Mendez-Tellez, P.A., Pronovost, P.J., Needham, D.M., Neuromuscular dysfunction acquired in critical illness: a systematic review. Intensive Care Med 33 (2007), 1876–1891.
85. [85] Demoule, A., Jung, B., Prodanovic, H., Molinari, N., Chanques, G., Coirault, C., et al. Diaphragm dysfunction on admission to the intensive care unit. Prevalence, risk factors, and prognostic impact-a prospective study. Am J Respir Crit Care Med 188 (2013), 213–219.
86. [86] Dres, M., Dube, B.P., Mayaux, J., Delemazure, J., Reuter, D., Brochard, L., et al. Coexistence and impact of limb muscle and diaphragm weakness at time of liberation from mechanical ventilation in medical ICU patients. Am J Respir Crit Care Med, 2016.
87. [87] Jung, B., Nougaret, S., Conseil, M., Coisel, Y., Futier, E., Chanques, G., et al. Sepsis is associated with a preferential diaphragmatic atrophy: a critically ill patient study using tridimensional computed tomography. Anesthesiology 120 (2014), 1182–1191.
88. [88] Helliwell, T.R., Coakley, J.H., Wagenmakers, A.J., Griffiths, R.D., Campbell, I.T., Green, C.J., et al. Necrotizing myopathy in critically-ill patients. J Pathol 164 (1991), 307–314.
89. [89] Deconinck, N., Van Parijs, V., Beckers-Bleukx, G., Van den Bergh, P., Critical illness myopathy unrelated to corticosteroids or neuromuscular blocking agents. Neuromuscul Disord 8 (1998), 186–192.
90. [90] Tennila, A., Salmi, T., Pettila, V., Roine, R.O., Varpula, T., Takkunen, O., Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis. Intensive Care Med 26 (2000), 1360–1363.
91. [91] Berek, K., Margreiter, J., Willeit, J., Berek, A., Schmutzhard, E., Mutz, N.J., Polyneuropathies in critically ill patients: a prospective evaluation. Intensive Care Med 22 (1996), 849–855.
92. [92] Tepper, M., Rakic, S., Haas, J.A., Woittiez, A.J., Incidence and onset of critical illness polyneuropathy in patients with septic shock. Neth J Med 56 (2000), 211–214.
93. [93] Garnacho-Montero, J., Amaya-Villar, R., Garcia-Garmendia, J.L., Madrazo-Osuna, J., Ortiz-Leyba, C., Effect of critical illness polyneuropathy on the withdrawal from mechanical ventilation and the length of stay in septic patients. Crit Care Med 33 (2005), 349–354.
94. [94] Bruells, C.S., Bergs, I., Rossaint, R., Du, J., Bleilevens, C., Goetzenich, A., et al. Recovery of diaphragm function following mechanical ventilation in a rodent model. PLoS One, 9, 2014, e87460.
95. [95] Thomas, D., Maes, K., Agten, A., Heunks, L., Dekhuijzen, R., Decramer, M., et al. Time course of diaphragm function recovery after controlled mechanical ventilation in rats. J Appl Physiol (1985) 115 (2013), 775–784.
96. [96] Powers, S.K., Smuder, A.J., Criswell, D.S., Mechanistic links between oxidative stress and disuse muscle atrophy. Antioxid Redox Signal 15 (2011), 2519–2528.
97. [97] Shanely, R.A., Van Gammeren, D., Deruisseau, K.C., Zergeroglu, A.M., McKenzie, M.J., Yarasheski, K.E., et al. Mechanical ventilation depresses protein synthesis in the rat diaphragm. Am J Respir Crit Care Med 170 (2004), 994–999.
98. [98] Picard, M., Jung, B., Liang, F., Azuelos, I., Hussain, S., Goldberg, P., et al. Mitochondrial dysfunction and lipid accumulation in the human diaphragm during mechanical ventilation. Am J Respir Crit Care Med 186 (2012), 1140–1149.
99. [99] Whidden, M.A., Smuder, A.J., Wu, M., Hudson, M.B., Nelson, W.B., Powers, S.K., Oxidative stress is required for mechanical ventilation-induced protease activation in the diaphragm. J Appl Physiol (1985) 108 (2010), 1376–1382.
100. [100] Hussain, S.N., Mofarrahi, M., Sigala, I., Kim, H.C., Vassilakopoulos, T., Maltais, F., et al. Mechanical ventilation-induced diaphragm disuse in humans triggers autophagy. Am J Respir Crit Care Med 182 (2010), 1377–1386.
101. [101] Hudson, M.B., Smuder, A.J., Nelson, W.B., Wiggs, M.P., Shimkus, K.L., Fluckey, J.D., et al. Partial support ventilation and mitochondrial-targeted antioxidants protect against ventilator-induced decreases in diaphragm muscle protein synthesis. PLoS One, 10, 2015, e0137693.
102. [102] Futier, E., Constantin, J.M., Combaret, L., Mosoni, L., Roszyk, L., Sapin, V., et al. Pressure support ventilation attenuates ventilator-induced protein modifications in the diaphragm. Crit Care, 12, 2008, R116.
103. [103] Powers, S.K., Shanely, R.A., Coombes, J.S., Koesterer, T.J., McKenzie, M., Van Gammeren, D., et al. Mechanical ventilation results in progressive contractile dysfunction in the diaphragm. J Appl Physiol (1985) 92 (2002), 1851–1858.
104. [104] Sassoon, C.S., Caiozzo, V.J., Manka, A., Sieck, G.C., Altered diaphragm contractile properties with controlled mechanical ventilation. J Appl Physiol (1985) 92 (2002), 2585–2595.
105. [105] Yang, L., Luo, J., Bourdon, J., Lin, M.C., Gottfried, S.B., Petrof, B.J., Controlled mechanical ventilation leads to remodeling of the rat diaphragm. Am J Respir Crit Care Med 166 (2002), 1135–1140.
106. [106] Hudson, M.B., Smuder, A.J., Nelson, W.B., Bruells, C.S., Levine, S., Powers, S.K., Both high level pressure support ventilation and controlled mechanical ventilation induce diaphragm dysfunction and atrophy. Crit Care Med 40 (2012), 1254–1260.
107. [107] Powers, S.K., Wiggs, M.P., Sollanek, K.J., Smuder, A.J., Ventilator-induced diaphragm dysfunction: cause and effect. Am J Physiol Regul Integr Comp Physiol 305 (2013), R464–R477.
108. [108] Jaber, S., Jung, B., Matecki, S., Petrof, B.J., Clinical review: ventilator-induced diaphragmatic dysfunction—human studies confirm animal model findings!. Crit Care, 15, 2011, 206.
109. [109] Levine, S., Nguyen, T., Taylor, N., Friscia, M.E., Budak, M.T., Rothenberg, P., et al. Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans. N Engl J Med 358 (2008), 1327–1335.
110. [110] Grosu, H.B., Lee, Y.I., Lee, J., Eden, E., Eikermann, M., Rose, K.M., Diaphragm muscle thinning in patients who are mechanically ventilated. Chest 142 (2012), 1455–1460.
111. [111] Schepens, T., Verbrugghe, W., Dams, K., Corthouts, B., Parizel, P.M., Jorens, P.G., The course of diaphragm atrophy in ventilated patients assessed with ultrasound: a longitudinal cohort study. Crit Care, 19(422), 2015 [015–1141-0].
112. [112] Jaber, S., Petrof, B.J., Jung, B., Chanques, G., Berthet, J.P., Rabuel, C., et al. Rapidly progressive diaphragmatic weakness and injury during mechanical ventilation in humans. Am J Respir Crit Care Med 183 (2011), 364–371.
113. [113] Hermans, G., Agten, A., Testelmans, D., Decramer, M., Gayan-Ramirez, G., Increased duration of mechanical ventilation is associated with decreased diaphragmatic force: a prospective observational study. Crit Care, 14, 2010, R127.
114. [114] Sharshar, T., Bastuji-Garin, S., De Jonghe, B., Stevens, R.D., Polito, A., Maxime, V., et al. Hormonal status and ICU-acquired paresis in critically ill patients. Intensive Care Med 36 (2010), 1318–1326.
115. [115] van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., et al. Intensive insulin therapy in critically ill patients. N Engl J Med 345 (2001), 1359–1367.
116. [116] Hermans, G., Wilmer, A., Meersseman, W., Milants, I., Wouters, P.J., Bobbaers, H., et al. Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. Am J Respir Crit Care Med 175 (2007), 480–489.
117. [117] Hermans, G., De Jonghe, B., Bruyninckx, F., Van den Berghe, G., Interventions for preventing critical illness polyneuropathy and critical illness myopathy. Cochrane Database Syst Rev, 1, 2014, CD006832.
118. [118] NICE-SUGAR Study Investigators, Finfer, S., Chittock, D.R., Su, S.Y., Blair, D., Foster, D., et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360 (2009), 1283–1297.
119. [119] NICE-SUGAR Study Investigators, Finfer, S., Liu, B., Chittock, D.R., Norton, R., Myburgh, J.A., et al. Hypoglycemia and risk of death in critically ill patients. N Engl J Med 367 (2012), 1108–1118.
120. [120] Chamberlain, J.J., Rhinehart, A.S., Shaefer, C.F. Jr., Neuman, A., Diagnosis and management of diabetes: synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes. Ann Intern Med, 2016.
121. [121] Dellinger, R.P., Levy, M.M., Rhodes, A., Annane, D., Gerlach, H., Opal, S.M., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39 (2013), 165–228.